United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 g - antifungal • cures most athlete’s foot, jock itch, and ringworm   • relieves itching, burning, cracking, scaling, and discomfort on children under 2 years, unless directed by a doctor. • irritation occurs    • there is no improvement within 4 weeks (for athlete’s foot and ringworm) or within 2 weeks (for jock itch)

United States - English - NLM (National Library of Medicine)

cvs pharmacy - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 g - antifungal - cures most athlete's foot, jock itch and ringworm - relieves itching, burning, cracking, scaling and discomfort which accompany these conditions

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 1 g in 1 ml - antifungal - cures most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) - effectively relieves - itching - cracking - burning - discomfort which can accompany these conditions

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 1 g in 1 ml - antifungal - cures most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) - effectively relieves - itching - cracking - burning - discomfort which can accompany these conditions

United States - English - NLM (National Library of Medicine)

chain drug consortium, llc - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 g - antifungal - cures most athlete’s foot, jock itch, and ringworm - relieves itching, burning, cracking, scaling, and discomfort

United States - English - NLM (National Library of Medicine)

cvs pharmacy - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 ml - antifungal - for the effective treatment of most athlete's foot (tinea pedis) and ringworm (tinea corporis)

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 1 g in 100 g - antifungal - cures most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) - for effective relief of - itching - scaling - cracking - burning - redness - soreness - irritation - discomfort

United States - English - NLM (National Library of Medicine)

lifelabs, a division of atico international usa, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 g - purpose antifungal uses - cures most athlete's foot, jock itch, and ringworm - relieves itching, burning, cracking, scaling and discomfort which accompany these conditions when using this product avoid contact with the eyes. stop use and ask a doctor if - irritation occurs - there is no improvement within 4 weeks (for athlete's foot and ringworm) or 2 weeks (for jock itch) - do not use for diaper rash

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole lozenges are indicated for the local treatment of oropharyngeal candidiasis. the diagnoses should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole lozenges are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole lozenges are contraindicated in patients who are hypersensitive to any of its components. safety and effectiveness of clotrimazole in children below the age of 3 years have not been established; therefore, its use in such patients is not recommended. the safety and effica

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximum